文献速递生殖医学

DLGAP5致病性变异导致以卵母细胞成熟阻滞和胚胎阻滞为特征的女性不孕

Pathogenic variants in DLGAP5 cause female infertility characterized by oocyte maturation arrest and embryonic arrest.
PubMed 文献 · Hum Reprod · 2025-01-01

研究通过对3627例卵母细胞成熟缺陷或胚胎发育问题的女性不孕患者进行全外显子测序,在两个独立家系的三例患者中鉴定出DLGAP5纯合和复合杂合变异。功能实验显示DLGAP5定位于纺锤体,敲低可损害纺锤体组装并导致卵母细胞成熟阻滞(P=0.0055),纯合敲入雌鼠生育力降低(P<0.0001),表现为4细胞期胚胎阻滞(P<0.0001)和低囊胚形成率(P<0.0001)。

要点

  • 在3627例不孕队列中鉴定出DLGAP5纯合无义变异和复合杂合变异。
  • 敲低人卵母细胞DLGAP5损害纺锤体组装并导致成熟阻滞(P=0.0055)。
  • 纯合敲入雌鼠生育力降低,4细胞期胚胎阻滞且囊胚形成率低(均P<0.0001)。

核心结论

  • DLGAP5参与人卵母细胞纺锤体组装,其变异在卵母细胞成熟阻滞的发病中起作用。
  • 作者认为DLGAP5是遗传咨询的新标志物。

研究设计与样本

  • 全外显子测序队列纳入3627例卵母细胞成熟缺陷或胚胎发育问题的女性不孕患者,招募时间为2015年至2023年。
  • 在HEK-293T细胞中转染36小时后用蛋白质印迹评估野生型和突变型DLGAP5表达(n=3生物学重复)。
  • 人胚泡卵母细胞用于cRNA注射(每组n=3-5个卵母细胞)和抗体注射(每组n=10-15个卵母细胞)。
  • 用CRISPR-Cas9构建敲入小鼠模型,于出生后第10-15天进行基因分型;性成熟雌鼠(6-10周龄)用于生育力测试(每组n=6只,持续6-8个月)及蛋白质印迹、IVF、胚胎收集、免疫荧光、RNA测序等功能实验(各n=3生物学重复),时间为2019年至2023年。
  • 采用Trim-Away敲低人卵母细胞DLGAP5以观察对纺锤体组装和卵母细胞成熟的影响。

主要发现

  • 家系1中两例患病姐妹携带纯合无义变异NM_014750.5 c.431delA(p.Lys144Argfs*55),家系2中一例不孕个体携带复合杂合变异c.C847G(p.Pro283Ala)和c.C1202G(p.Thr401Ser)。
  • p.Lys144Argfs*55导致蛋白质降解(P<0.0001),p.Pro283Ala导致蛋白质水平显著降低(P=0.0021)。
  • DLGAP5定位于纺锤体,突变未改变其定位。
  • 敲低人卵母细胞DLGAP5损害纺锤体组装并导致卵母细胞成熟阻滞(P=0.0055)。
  • 纯合敲入雌鼠生育力降低(P<0.0001),表现为4细胞期胚胎阻滞(P<0.0001)和低囊胚形成率(P<0.0001)。

临床怎么用

  • 作者认为DLGAP5是遗传咨询的新标志物。

局限性

  • 由于不同DLGAP5变异存在表型差异,需要更多病例来扩展对DLGAP5在女性不孕中功能的理解。
  • 尽管RNA测序数据提示DLGAP5对细胞周期、胚胎发育和TGF-β信号调控的潜在影响,仍需更多实验证明DLGAP5在卵母细胞和胚胎发育中更直接的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can new genetic factors responsible for oocyte defects be identified in infertile women, especially for those with spindle assembly defects? SUMMARY ANSWER: We identified homozygous and compound heterozygous variants of DLGAP5 in three infertile individuals from two independent families. WHAT IS KNOWN ALREADY: Some genes have been found to be responsible for female infertility with oocyte maturation defects. During mitosis, DLGAP5 is involved in promoting microtubule polymerization and spindle formation. STUDY DESIGN, SIZE, DURATION: The DLGAP5 variants were identified by whole-exome sequencing in a cohort of 3627 female infertility patients diagnosed with oocyte maturation defects or embryonic development problems, and all participants were recruited from 2015 to 2023. Thirty-six hours after cell transfection, the expression levels of wild-type (WT) and mutant DLGAP5 were evaluated by western blot (n = 3 biological replicates). Human germinal vesicle (GV) oocytes retrieved from assisted reproductive procedure were introduced for cRNA (n = 3-5 oocytes per group) and antibody injection (n = 10-15 oocytes per group). Knock-in (KI) mouse model was generated by CRISPR-Cas9 and genotyping was performed at postnatal Days 10-15. Sexually mature females (6-10 weeks old) were used for fertility test (n = 6 mice per group, lasts 6-8 months), western blot (n = 3 biological replicates), IVF (n = 3 biological replicates), embryos collection (n = 3 biological replicates), immunofluorescence (n = 3 biological replicates), RNA-sequencing (RNA-seq, n = 3 biological replicates), and other functional assays between 2019 and 2023. PARTICIPANTS/MATERIALS, SETTING, METHODS: The DLGAP5 variants were identified by whole-exome sequencing and further confirmed by Sanger sequencing. Western blot was used to detect the expression of mutant DLGAP5 in HEK-293T cells after transfection. cRNA injection and immunofluorescence were performed to view the location of DLGAP5 in human oocytes. Knockdown of DLGAP5 by Trim-Away in human oocytes was conducted to observe the effect of DLGAP5 on spindle assembly and oocyte maturation. Then, Dlgap5 KI mice were constructed to mimic the phenotype of the affected individuals. After phenotypic assessment, western blot, IVF, assessment of embryonic development, chromosome counting, RNA-seq, and quantitative real-time PCR were performed to elucidate the pathological mechanism of DLGAP5 variants. MAIN RESULTS AND THE ROLE OF CHANCE: We identified homozygous nonsense DLGAP5 variant (NM_014750.5, c.431delA (p.Lys144Argfs*55)) in two affected sisters from family 1 and compound heterozygous variants (c.C847G (p.Pro283Ala) and c. C1202G (p.Thr401Ser)) in one infertile individual in family 2. p. Lys144Argfs*55 led to protein degradation (P < 0.0001) and p. Pro283Ala resulted in a significant decrease in protein level (P = 0.0021). DLGAP5 was located on the spindle and mutant did not alter its location. Knockdown of DLGAP5 in human oocytes impaired spindle assembly and led to oocyte maturation arrest (P = 0.0055). Homozygous (HO) Dlgap5 KI female mice showed reduced fertility (P < 0.0001) due to embryonic arrest at the 4-cell stage (P < 0.0001) and a low blastocyst formation rate (P < 0.0001). RNA-seq data of 4-cell embryos showed that differentially expressed genes (DEGs) were involved in cell cycle regulation, checkpoint control, and TGF-β signaling pathways, which may account for the embryonic development arrest. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Due to phenotypic differences between different DLGAP5 variants, more cases are needed to expand our understanding of the function of DLGAP5 in female infertility. Although RNA-seq data have shown the potential impact of DLGAP5 on cell cycle, embryonic development, and regulation of TGF-β signaling, more experiments are still requested to demonstrate the more direct role of DLGAP5 in oocyte and embryonic development. WIDER IMPLICATIONS OF THE FINDINGS: Our findings elucidated the role of DLGAP5 in human oocyte spindle assembly and the effects of the corresponding variants in the pathogenesis of oocyte maturation arrest, and these findings suggest that DLGAP5 is a novel maker for genetic counseling. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Key Research and Development Program of China (2024YFC2706600), the National Natural Science Foundation of China (82325021, 82288102, 32130029, 82371662, 82171643, 82201767, 82422033), the National Key Research and Development Program of China (2022YFC2702300), the New Cornerstone Science Foundation through the XPLORER PRIZE, L.W. is a SANS Exploration Scholar, and the Fund of Fudan University and Cao'ejiang Basic Research (24FCB01). None of the authors declare any conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Qu R, Liang F, Fan L, et al. Pathogenic variants in DLGAP5 cause female infertility characterized by oocyte maturation arrest and embryonic arrest. Hum Reprod. 2025. PMID: 40639803. doi:10.1093/humrep/deaf139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。